Immune cell activation by novel hexavalent CD40 agonist APG1233 compared to trimeric formats or agonistic anti-CD40 antibodies. (December 2016) - Richards, D.M.; Merz, C.; Sykora, J.; Thiemann, M.; Beyer, T.; Kuehn, S.; Fricke, H.; Gieffers, C.; Hill, O.